Effectiveness and optimal duration of early intervention treatment in adult-onset psychosis: a randomized clinical trial
- 11 February 2022
- journal article
- research article
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 53 (6) , 2339-2351
Abstract
Background: Contrasting the well-described effects of early intervention (EI) services for youth-onset psychosis, the potential benefits of the intervention for adult-onset psychosis are uncertain. This paper aims to examine the effectiveness of EI on functioning and symptomatic improvement in adult-onset psychosis, and the optimal duration of the intervention.Methods: 360 psychosis patients aged 26–55 years were randomized to receive either standard care (SC, n = 120), or case management for two (2-year EI, n = 120) or 4 years (4-year EI, n = 120) in a 4-year rater-masked, parallel-group, superiority, randomized controlled trial of treatment effectiveness (Clinicaltrials.gov: NCT00919620). Primary (i.e. social and occupational functioning) and secondary outcomes (i.e. positive and negative symptoms, and quality of life) were assessed at baseline, 6-month, and yearly for 4 years.Results: Compared with SC, patients with 4-year EI had better Role Functioning Scale (RFS) immediate [interaction estimate = 0.008, 95% confidence interval (CI) = 0.001–0.014, p = 0.02] and extended social network (interaction estimate = 0.011, 95% CI = 0.004–0.018, p = 0.003) scores. Specifically, these improvements were observed in the first 2 years. Compared with the 2-year EI group, the 4-year EI group had better RFS total (p = 0.01), immediate (p = 0.01), and extended social network (p = 0.05) scores at the fourth year. Meanwhile, the 4-year (p = 0.02) and 2-year EI (p = 0.004) group had less severe symptoms than the SC group at the first year.Conclusions: Specialized EI treatment for psychosis patients aged 26–55 should be provided for at least the initial 2 years of illness. Further treatment up to 4 years confers little benefits in this age range over the course of the study.Keywords
This publication has 38 references indexed in Scilit:
- Cognitive and symptomatic predictors of functional disability in schizophreniaSchizophrenia Research, 2011
- Early intervention services, cognitive–behavioural therapy and family intervention in early psychosis: systematic reviewThe British Journal of Psychiatry, 2010
- Outcome measures in early psychosisThe British Journal of Psychiatry, 2007
- Schizophrenia in Translation: Is Active Psychosis Neurotoxic?Schizophrenia Bulletin, 2005
- A 12-Item Short-Form Health SurveyMedical Care, 1996
- The Influence of Age and Sex on the Onset and Early Course of SchizophreniaThe British Journal of Psychiatry, 1993
- Age Differences in Adult Life Goals, Concerns, and Their Temporal Extension: A Life Course Approach to Future-oriented MotivationInternational Journal of Behavioral Development, 1992
- The UKU side effect rating scale: A new comprehensive rating scale for psychotropic drugs and a cross‐sectional study of side effects in neuroleptic‐treated patientsActa Psychiatrica Scandinavica, 1987
- A Rating Scale for Mania: Reliability, Validity and SensitivityThe British Journal of Psychiatry, 1978
- A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTSActa Psychiatrica Scandinavica, 1970